Skip to main content
S&P 5007,619.38+1.31%DOW52,486.49+0.49%NASDAQ25,466.19+1.60%BTC$73,579.00-0.07%ETH$2,047.08-0.37%GOLD$3,993.80-0.17%OIL$85.47-1.23%
Smart Investors Daily
SID Premium
MR

OTC · MRMD

MariMed Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$0.08

Up+$0.00 (+3.45%)

Updated Nov 12, 2026, 9:53 AM

SID Score

4.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
29.63M
P/E ratio
-1.84
Dividend yield
0.00%
52-week range
— – —
Volume
534.95K
Avg. volume
1.2M

Price performance · MRMD

MRMD price history

1M range · 0 trading sessions · Daily adjusted prices

MRMD does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest MRMD news

The latest Smart Investors Daily articles mentioning MRMD.

Stock researchCompany · Overview

MRMD research

Overview

Company profile and research snapshot.

Company profile

MARIMED INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$2.25
Implied upside
—
Analysts
—
MRMD recent ratings
DateFirmRatingTarget
Nov 6, 2023Zuanic & AssociatesOverweight—
Oct 28, 2022BTIGBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 29, 2026

MariMed Stockholders Approve Proposed Reverse Stock Split

NORWOOD, Mass., Oct. 29, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced that the Company’s Stockholders approved a proposed reverse stock split of the Company’s common stock (the “Reverse Stock Split”) at a Special Meeting of Stockholders (the “Special Meeting”) held October 28, 2026. “I want to thank our Shareholders for their overwhelming support in appro

Yahoo · Oct 20, 2026

MariMed Announces Third Quarter 2026 Earnings Date

NORWOOD, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its third quarter 2026 financial results on November 11, 2026 after the markets close. Management will host a conference call on November 12, 2026 at 8:00 a.m. EDT to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations website at

Yahoo · Sep 24, 2026

MariMed’s Betty’s Eddies Spreads Importance of Cancer Screening Education and Awareness this October through Partnership with Keep A Breast Foundation

Fourth Annual Collaboration Coincides with Breast Cancer Awareness MonthNORWOOD, Mass., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Betty’s Eddies™, the all-natural cannabis fruit chews handcrafted for specific health and wellness effects, announced today its fourth annual collaboration with the Keep A Breast Foundation (“KAB”). The collaboration, which furthers the brand’s commitment to breast cancer awareness, early screening education, and community support, kicks off this week as a lead-up to October

Yahoo · Sep 23, 2026

MariMed Files Definitive Proxy Statement for Special Meeting of Stockholders to Approve Proposed Reverse Stock Split

NORWOOD, Mass., Sept. 23, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission (“SEC”) in connection with a Special Meeting of Stockholders (the “Special Meeting”) to seek stockholder approval of a proposed reverse stock split of the Company’s common stock (the “Revers

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By